
|Articles|December 1, 2004
Nidek reaches milestone in hyperopia study
Fremont, CA-Nine months into its hyperopia clinical study, Nidek has analyzed 248 of the 300 eyes to be studied for the treatment of hyperopia and hyperopic astigmatism.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
2
First patient treated in ViaLase’s IDE trial
3
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5















































.png)


